Theravance Biopharma Inc logo

Theravance Biopharma Inc

NEW
NAS:TBPH (Cayman Islands)  
$ 8.24 -0.23 (-2.72%) 04:00 PM EST
At Loss
P/B:
2.08
Market Cap:
$ 403.12M
Enterprise V:
$ 364.95M
Volume:
142.10K
Avg Vol (2M):
183.26K
Trade In:
Volume:
142.10K
At Loss
Avg Vol (2M):
183.26K

Business Description

Description
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Name Current Vs Industry Vs History
Cash-To-Debt 2.06
Equity-to-Asset 0.54
Debt-to-Equity 0.24
Debt-to-EBITDA -1.5
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.98
Distress
Grey
Safe
Beneish M-Score -2.9
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.99
9-Day RSI 47.78
14-Day RSI 50.79
6-1 Month Momentum % -4.5
12-1 Month Momentum % -13.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.2
Quick Ratio 5.2
Cash Ratio 4.19
Days Sales Outstanding 93.33

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 9.2
Shareholder Yield % 16.29

Financials (Next Earnings Date:2024-11-12)

TBPH's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TBPH

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Theravance Biopharma Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 62.017
EPS (TTM) ($) -0.92
Beta 0.05
Volatility % 37.52
14-Day RSI 50.79
14-Day ATR ($) 0.240873
20-Day SMA ($) 8.4365
12-1 Month Momentum % -13.33
52-Week Range ($) 7.44 - 11.71
Shares Outstanding (Mil) 48.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Theravance Biopharma Inc Filings

Filing Date Document Date Form
No Filing Data

Theravance Biopharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Theravance Biopharma Inc Frequently Asked Questions

What is Theravance Biopharma Inc(TBPH)'s stock price today?
The current price of TBPH is $8.24. The 52 week high of TBPH is $11.71 and 52 week low is $7.44.
When is next earnings date of Theravance Biopharma Inc(TBPH)?
The next earnings date of Theravance Biopharma Inc(TBPH) is 2024-11-12.
Does Theravance Biopharma Inc(TBPH) pay dividends? If so, how much?
Theravance Biopharma Inc(TBPH) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1